Sign inJoin waitlistJoin the waitlist

FF

Faye Feller

Internal Medicine

Credentials: ·

History

Medical Oncology
Internal Medicine

Research

Imetelstat in patients with lower-risk myelodysplastic syndromes who have relapsed or are refractory to erythropoiesis-stimulating agents (IMerge): a multinational, randomised,…
The Lancet · 2024 · 125 citations
Imetelstat Achieves Meaningful and Durable Transfusion Independence in High Transfusion-Burden Patients With Lower-Risk Myelodysplastic Syndromes in a Phase II Study
Journal of Clinical Oncology · 2021 · 113 citations
Randomized, Single-Blind, Multicenter Phase II Study of Two Doses of Imetelstat in Relapsed or Refractory Myelofibrosis
Journal of Clinical Oncology · 2021 · 95 citations

TB
Tymara Berry
10 papers
RK
Rami Komrokji
9 papers
Amer Zeidan
6 papers
Michael Savona
6 papers
Mikkael Sekeres
6 papers
SN
Shyamala Navada
6 papers
Yazan Madanat
6 papers
John Mascarenhas
4 papers
Peter Morcos
4 papers
Azra Raza
3 papers
Ronald Hoffman
2 papers
AK
Andrew Kuykendall
1 paper